- Home
- / Entera Bio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Entera Bio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.9
2024-10-29
Market Capitalization
$68.7 M
2024-10-29
Revenue
$42 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 500.0K | 236.0K | 365.0K | 571.0K | 134.0K | 181.0K | 42.0K | |
| Cost of goods sold | 210.0K | 209.0K | 373.0K | 101.0K | 172.0K | 42.0K | ||
| Gross profit | 26.0K | 156.0K | 198.0K | 33.0K | 9.0K | |||
| Gross profit margin, % | 11.0% | 42.7% | 24.6% | 5.0% | ||||
| General and administrative expense | 2.8M | 4.3M | 4.9M | 5.7M | 7.3M | 4.4M | 5.1M | 5.5M |
| Operating expense total | 11.4M | 11.5M | 11.3M | 13.1M | 8.9M | 9.6M | 11.5M | |
| Depreciation and amortization | 30.0K | |||||||
| EBIT | (8.9M) | (9.6M) | ||||||
| EBIT margin, % | -5295.6% | |||||||
| Pre tax profit | (10.0M) | (12.2M) | (12.9M) | (8.9M) | (9.5M) | (11.4M) | ||
| Income tax expense | 20.0K | (59.0K) | 137.0K | 29.0K | 14.0K | |||
| Net Income | (8.9M) | (9.5M) | ||||||
| EPS | 0.5 | 0.3 | 0.3 |